/oss/taxonomy/term/5474/all en /oss/article/health/alzheimers-breakthrough-hardly <p>Alzheimer’s is a terrifying disease. Since no new medications for this condition have been introduced for about two decades, it is certainly understandable that any new drug that receives regulatory agency approval attracts media attention. This is indeed the case for Aduhelm (aducanumab), recently approved by the U.S. Food and Drug Administration. That approval, however, is riddled with controversy.</p> Sat, 12 Jun 2021 04:10:10 +0000 Joe Schwarcz PhD 8762 at /oss